Al-Dawaa, a pharmaceutical retail firm in Saudi Arabia, has set the price range for its initial public offering at SR65 ($17.3) to SR73 per share.
The company earlier announced it was offering 25.5 million shares in an IPO, or 30 percent of its capital of SR850 million through a sale by existing shareholders.
Institutional subscription has also started on Sunday, where they are initially allocated 100 percent of the offering, but could go down to 90 percent, Al-Dawaa said in a statement.
The most important news stories of the day, curated by Post editors and delivered every morning.
By signing up you agree to our Terms of Use and Privacy Policy.
Business and leisure combo drives GCC tourism boom
Audi’s sustainable Middle East luxury drive
Saudi Film “Norah”, backed by Red Sea Fund, secures official selection at Cannes
From sand dunes to boardrooms: Strategies for success in challenging times
Top U.S. stock indices drop for third consecutive day on Wednesday
GCC countries mobilize to build resilient industrial supply chains: report
Despite sanctions, Iran oil exports hit six-year high: report
